Stay up-to-date on current diabetes themes, proven therapeutic options, and knowledge resources and tools for you and your patients, and find detailed information on Novo Nordisk diabetes products.
Since the launch of its first pen needle in 1985, Novo Nordisk has been committed to enhancing injection experience by putting technology in patient hands. NovoFine® Plus is the latest example of that commitment.
We have products for rare bleeding disorders, growth hormone-related disorders, and women’s health.
Chronic Weight Management
Find information on our treatment for chronic weight management in adults who are overweight with one weight-related comorbidity or obesity.
Making a positive difference in people’s lives is at the heart of everything Novo Nordisk does – through groundbreaking science, sustained focus on the environment, and patient-centered care.
Our Media Relations team is ready to help you get all the information you need about Novo Nordisk.
Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) approved Fiasp® (insulin aspart injection) 100 Units/mL, a fast-acting mealtime insulin indicated to improve glycemic...
Taking Diabetes to Heart is a global online survey for people with type 2 diabetes to gain important insights about their awareness of cardiovascular disease (CVD) Globally, CVD is the most common...
Novo Nordisk in the U.S. has been named to the "Working Mother 100 Best Companies" list which recognizes companies for their strong leadership in creating progressive workforce programs regarding...
Today, Novo Nordisk announced it has reached a resolution with the U.S. federal government and the states about an investigation launched in February 2011 concerning sales and marketing practices...
Visit the download center to download Novo Nordisk video and more
Sign up to receive our new alerts